About this Research Topic
In this research topic I would like to put an emphasis on clinical outcomes in AAV patients, both in terms of disease outcomes but also in terms of treatment complications such as infections, cardiovascular complications and malignancies. Biomarkers of diseases activity as well as outcome predictors are interesting as well because we still use clinical presentations and standard laboratory tests to assess disease activity. Last but not least I feel more emphasis has to be not only on clinical and laboratory outcomes but also on patient quality of life including also initial patient presentation such as frailty which I believe influences treatment options as well as complications and outcomes.
This Research Topic accepts Original Research, Systematic Review, Review, Clinical Trial and Brief Research Report. We welcome manuscripts focusing on, but not limited to, the following sub-topics:
• Clinical outcomes in ANCA vasculitis patients
• Biomarkers in ANCA vasculitis
• Treatment and disease complications in ANCA vasculitis patients (including infectious complications, cardiovascular complications and malignancies)
• Patient frailty and quality of life
Topic Editor Giacomo Emmi receives financial support for consultancy and advisory board from Gsk, AstraZeneca, Sobi, Novartis, Vifor, and Boheringer. The other Topic Editors declare no competing interests with regard to the Research Topic subject.
Keywords: ANCA; vasculitis; outcomes; complications; biomarkers; patient frailty/quality of life
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.